Episode 19: Mefloquine Poisoning
Mefloquine (brand name Lariam) was an anti-malarial drug widely used by the U.S. military from the 1990’s until roughly 2004 during the Iraq and Afghanistan conflicts. In 2013, the FDA placed its strongest warning, the Black Box warning, on the drug due to reports of ongoing or permanent neurological and psychiatric conditions that can sometimes mirror PTSD. Some veterans may be experiencing the lasting effects of mefloquine toxicity to this day.
On this episode of the Veterans Legal Lowdown, CCK attorneys Courtney Ross and Emma Peterson are joined by Dr. Remington Nevin, a leading expert on Mefloquine exposure among troops and a veteran himself, to discuss the drug and the consequences its use may have had on those who served.
- Hearing loss denial contained legal error by Board
- Board Commits Legal Error in Denying Service Connection for Psychiatric Condition
- CCK Presents at Veterans Law Continuing Legal Education Conference in Montana
- Thrombosis denial contained legal error by the BVA
- Board Denial of Service Connection for Cause of Death Contained Legal Error
- What is the Process in a Court of Appeals for Veterans Claims (CAVC) or Veterans Court Appeal?
- What is the CAVC, or Veterans Court?
- Getting Veterans (VA) Disability for Toxic Water at Camp Lejeune
- Are Veterans Disability Benefits Taxable?
- Is RAMP a Part of the Veterans Appeals Improvement and Modernization Act of 2017?
- Monk v. Wilkie: Class Actions at the Court of Appeals for Veterans Claims (CAVC)
- Blue Water Navy Veterans Update – June 2019
- CCK Partners with Harvard Law School to Launch Veterans Legal Clinic
- BREAKING NEWS: Court Rules Blue Water Navy Veterans Should Be Eligible for Agent Orange Presumption
- New Laws for Veterans and Servicemembers in 2020
Share this Post